Arixa Pharmaceuticals Patents – Insights & Stats (Updated 2023)

Arixa Pharmaceuticals has a total of 75 patents globally, out of which 26 have been granted. Of these 75 patents, more than 84% patents are active. The United States of America is where Arixa Pharmaceuticals has filed the maximum number of patents, followed by Canada and Australia. Parallelly, United States of America seems to be the main focused R&D centre and also is the origin country of Arixa Pharmaceuticals.

Arixa Pharmaceuticals was founded in 2016 and is a subpart of Pfizer. Arixa Pharmaceuticals works on researching oral antibiotics for resistant Gram-negative bacterial infections. Their main initiative is production of an oral prodrug of the recently FDA-approved broad spectrum beta-lactamase inhibitor Avibactam.

Do read about some of the most popular patents of Arixa Pharmaceuticals which have been covered by us in this article and also you can find Arixa Pharmaceuticals patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Arixa Pharmaceuticals patent portfolio.

How many patents do the Founder and CEO of Apple have?

The Founder Eric Gordon has 0 patent and CEO John Freund (also founder) has 43 patents respectively.

How many patents does Arixa Pharmaceuticals have?

Arixa Pharmaceuticals has a total of 75 patents globally. These patents belong to 9 unique patent families. Out of 75 patents, 63 patents are active.

How Many Patents did Arixa Pharmaceuticals File Every Year?

Arixa Pharmaceuticals Patent Filing Trend

Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.

Year of Patents Filing or GrantArixa Pharmaceuticals Applications FiledArixa Pharmaceuticals Patents Granted

How many Arixa Pharmaceuticals patents are Alive/Dead?

Worldwide Patents

Arixa Pharmaceuticals Patent Portfolio

How Many Patents did Arixa Pharmaceuticals File in Different Countries?

Arixa Pharmaceuticals Worldwide Patent   Portfolio

Countries in which Arixa Pharmaceuticals Filed Patents

United States Of America16
Hong Kong (S.A.R.)4
New Zealand3
South Africa2

Where are Research Centers of Arixa Pharmaceuticals Patents Located?

R&D Centres of Arixa Pharmaceuticals

Best Arixa Pharmaceuticals Patents

US10085999B1 is the most popular patent in the Arixa Pharmaceuticals portfolio. It has received 15 citations so far from companies like Qpex Biopharma, Merck & Co and Shandong Anxin Pharmaceutical.

Below is the list of most cited patents of Arixa Pharmaceuticals:

Publication NumberCitation Count

What Percentage of Arixa Pharmaceuticals US Patent Applications Were Granted?

Arixa Pharmaceuticals (Excluding its subsidiaries) has filed 13 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 10 have been granted leading to a grant rate of 90.91%.

Below are the key stats of Arixa Pharmaceuticals patent prosecution at the USPTO.

Which Law Firms Filed Most US Patents for Arixa Pharmaceuticals?

Law FirmTotal ApplicationsSuccess Rate
Pfizer Inc1390.91%

What are Arixa Pharmaceuticals key innovation segments?

What Technologies are Covered by Arixa Pharmaceuticals?

The chart below distributes patents filed by Arixa Pharmaceuticals in different countries on the basis of the technology protected in patents. It also represents the markets where Arixa Pharmaceuticals thinks it’s important to protect particular technology inventions.

R&D Focus: How has Arixa Pharmaceuticals search focus changed over the years?


Interested in knowing about the areas of innovation that are being protected by Arixa Pharmaceuticals?

Related Articles

Leave a Comment

Fill the form to get the details:

Our comprehensive report provides an in-depth look into the patent portfolio. The report includes a breakdown of the patent portfolio across various technologies, listing the patent along with brief summaries of each patent's technology.